SCHEMBL10926631

SCHEMBL10926631

Cc1ccc(C(=O)c2noc(CC(=O)O)n2)cc1.Cc1ccc(C(=O)c2noc(CC(=O)O)n2)cc1.NC(=O)Cc1nc(C(=O)c2ccc(F)cc2)no1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 3/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ P2RY14 Q15391 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CXCL8 P10145 1/20 0.36
▸ AKR1B1 P15121 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ GLO1 Q04760 1/20 0.36
▸ GRM5 P41594 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10923821 0.89 ALDH1A1 (0.42) LMNAALDH1A1MAPTSMN1; SMN2TSHR
SCHEMBL10922342 0.89 LTA4H (0.39) MAPTSMN1; SMN2GRM5TSHRMEN1
SCHEMBL10925925 0.88 MAPT (0.41) LMNAMAPTSMN1; SMN2AKR1B1TSHR
SCHEMBL10925607 0.88 CXCL8 (0.43) LMNAALDH1A1MAPTSMN1; SMN2CXCL8
SCHEMBL10925296 0.79 ATM (0.39) ALDH1A1MAPTSMN1; SMN2TDP1TSHR
SCHEMBL10926847 0.76 MAPT (0.43) LMNAALDH1A1MAPTSMN1; SMN2TSHR
SCHEMBL10925378 0.76 KMT2A (0.44) ALDH1A1MAPTSMN1; SMN2AKR1B1MEN1
SCHEMBL10926174 0.76 LMNA (0.44) LMNAALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL10922810 0.75 TSHR (0.48) LMNAALDH1A1MAPTSMN1; SMN2PTGS2
SCHEMBL10926682 0.74 MAPT (0.51) LMNAALDH1A1MAPTSMN1; SMN2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0189080-A2 (1,2,4-Oxadiazol-3-YL)-arylmethanones, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1986-07-30 — — EP disclosed
Send feedback